Yossi Bornstein

During the past 35 years, Mr. Yossi Bornstein has played key roles in the Israeli & International biomed industry.

He was the General Manager of Bristol-Myers Squibb (Israel).

Mr. Bornstein is the CEO and the founder of Shizim Group, a leading life science holding company. He is the Founder of ShizimXL, medical devices innovation center and ShizimVS, digital health innovation center. He is the Chairman of GCP Clinical Studies Ltd., one of the providers of clinical research services and educational programs in Israel. He served as the Biotechnology Committee Chairman of the United States-Israel Science & Technology Commission (the “USISTC”). Mr. Bornstein is the founder of ILSI – Israel Life Science Industry Organization (who was integrated into IATI) and Founder of ITTN – Israel Tech Transfer Organization. He is a Co-Founder & director of Microbot Medical (NASDAQ: MBOT) and a Co-Founder  & Director of XACT Robotics. He serves as an External Director of Can-Fite BioPharma (NASDAQ: CANF)